GREACE STUDY PDF

May 4, 2019 posted by

The GREACE study emphasizes the urgent need for a wider use of lipid-lowering drugs in high-risk patients. Evaluation (GREACE) Study consisted of patients with coronary heart disease (CHD) followed up for three years1. The patients were randomised to either. Our post-hoc analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study was done to address this issue. Because of the.

Author: Dutilar Gojora
Country: Cuba
Language: English (Spanish)
Genre: Spiritual
Published (Last): 1 January 2011
Pages: 286
PDF File Size: 2.32 Mb
ePub File Size: 17.10 Mb
ISBN: 955-1-45184-160-7
Downloads: 78152
Price: Free* [*Free Regsitration Required]
Uploader: Dit

By posting or uploading Material you warrant and represent that: Recommend to your librarian. Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality.

During this study F does not claim any ownership in the Material that you or any other user posts. Accordingly you may only post Material that you have the right to do so. I would like to receive updates when further comments, recommendations, or dissenting opinions are publishing on this article.

Any view or opinion expressed in any Material is the view or opinion of the person who posts such view or opinion.

These terms shall be governed by and construed in accordance with English Law. Stydy use of certain tools provided by this website is subject to additional Terms and Conditions. User comments must be in English, comprehensible and relevant to the article under discussion. All patients were followed up for a mean period of 3 years. Neither of the above. Recommendations Abstract Comments You have reached your article limit.

Register Already registered with FPrime? By posting Material you grant to Sstudy an irrevocable non-exclusive royalty-free license to keep a copy of Material for a reasonable period and as necessary to enable it to comply with its legal obligations.

GREACE (GREek Atorvastatin Coronary-heart-disease Evaluation) study

You have a close personal relationship e. You may not use the website for any unlawful purpose, including without limitation, to upload, post, download or otherwise use any Material that you do not have the copyright owners permission to so upload, post, download or otherwise use, or that would result in you being in breach of these terms and conditions. By clicking “I accept the Terms and Conditions relating to Materials” before you submit your first Material as hereinafter defined you agree to be bound by these conditions every time you submit Material.

  ESCAPE BY BARBARA DELINSKY PDF

However, there is no long-term survival study that evaluated this statin. Withdrawal of patients because of side-effects from the atorvastatin group was low 0. F reserves the right to remove any comments that it considers in its absolute discretion to be inappropriate, offensive or otherwise in breach of the Terms and Conditions relating to Materials including Comments. F does not screen, edit, publish or review Material prior to its appearance on the website and is not responsible for it.

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Consider the following examples, but note that this is not an exhaustive list: This entry form currently does not support special characters. Long-term statin treatment reduces the frequency of cardiovascular events, but safety and efficacy in patients with abnormal liver tests is unclear.

F reserves the right to monitor all Material and to remove any Material which it considers in its absolute discretion to be unlawful, inappropriate, offensive or otherwise in breach of these Terms and Conditions.

You are an Editor for the journal in which the article is published.

Secondary endpoints were the safety and efficacy of the hypolipidaemic drugs as well as the cost-effectiveness of atorvastatin. All subgroups of patients women, those with diabetes mellitus, arterial hypertension, age 60 to 75 years, congestive heart failure, recent unstable angina or prior revascularisation benefited from treatment with atorvastatin. F does not store recipient email addresses. Recommend FPrime to your librarian or information manager to request an extended free trial for all users at your institution.

In detail, atorvastatin reduced, in comparison to ‘usual’ care, total mortality RR 0. Statin treatment is safe and can improve liver tests and reduce cardiovascular morbidity in patients with mild-to-moderately abnormal liver tests that are potentially attributable to non-alcoholic fatty liver disease. You hereby agree to indemnify and keep indemnified F, its affiliates, contractors and agents from and against any and all losses including without limitation direct, indirect and consequential losscosts, claims, damages or expenses of whatever nature and howsoever caused arising directly or indirectly from any breach of these Terms and Conditions or arising from the Material posted on this website or content contained in any email sent using the facilities provided by the studj by you including without limitation as a result of any infringement of any intellectual property or other proprietary rights, libel, defamation, obscenity or the Material being otherwise unlawful.

  KSP 2222A DATASHEET PDF

Primary endpoints of the study were defined as death, non-fatal myocardial infarction, unstable angina, congestive heart failure, revascularisation coronary morbidity and stroke. Treatment with atorvastatin is well tolerated and cost-effective. I am a Faculty Member who greacw this article. Register for day free trial Registration is free and only takes gerace moment, or subscribe for unlimited access. Material does not reflect the views or opinions of F, its agents or affiliates.

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. – Semantic Scholar

Erratum in Curr Med Res Opin. This Agreement shall begin on the date hereof.

Long-term treatment of CHD patients with atorvastatin to achieve NCEP lipid targets significantly reduces total and coronary mortality, coronary morbidity and stroke, in comparison to patients receiving ‘usual’ stusy care. I am an author of this article. Consider the following examples, but note that this is not an exhaustive list:.